OrbiMed’s Travere Therapeutics TVTX Stock Holding History

OrbiMed’s Portfolio TVTX Stock Details TVTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$32.5M	Buy
2023 Q1	$39.2M	Buy
2022 Q4	$26.4M	Hold
2022 Q3	$30.9K	Buy
2022 Q2	$18.7K	Buy
2021 Q2	–	Sell
2021 Q1	$13.2M	Buy